A TRIAL OF SODIUM VALPROATE IN TARDIVE-DYSKINESIA

This study reports the results of an open trial of Sodium Valproate in tardive-dyskinesia. Fifteen patients identified having tardive dyskinesia by two psychiatrists independently were treated with Sodium Valproate in dosage of 1200 mg/day for 4 weeks. Assessments were made on abbreviated Dyskinesia...

Descripción completa

Detalles Bibliográficos
Autores principales: Chadda, R., Kulhara, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 1986
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172504/
https://www.ncbi.nlm.nih.gov/pubmed/21927146
_version_ 1782211886943567872
author Chadda, R.
Kulhara, P.
author_facet Chadda, R.
Kulhara, P.
author_sort Chadda, R.
collection PubMed
description This study reports the results of an open trial of Sodium Valproate in tardive-dyskinesia. Fifteen patients identified having tardive dyskinesia by two psychiatrists independently were treated with Sodium Valproate in dosage of 1200 mg/day for 4 weeks. Assessments were made on abbreviated Dyskinesia Scale. There was statistically significant improvement after 2 and 4 weeks of treatment. Authors found Sodium Valproate quite effective in the management of tardive-dyskinesia.
format Online
Article
Text
id pubmed-3172504
institution National Center for Biotechnology Information
language English
publishDate 1986
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-31725042011-09-16 A TRIAL OF SODIUM VALPROATE IN TARDIVE-DYSKINESIA Chadda, R. Kulhara, P. Indian J Psychiatry Original Article This study reports the results of an open trial of Sodium Valproate in tardive-dyskinesia. Fifteen patients identified having tardive dyskinesia by two psychiatrists independently were treated with Sodium Valproate in dosage of 1200 mg/day for 4 weeks. Assessments were made on abbreviated Dyskinesia Scale. There was statistically significant improvement after 2 and 4 weeks of treatment. Authors found Sodium Valproate quite effective in the management of tardive-dyskinesia. Medknow Publications 1986 /pmc/articles/PMC3172504/ /pubmed/21927146 Text en Copyright: © Indian Journal of Psychiatry http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Chadda, R.
Kulhara, P.
A TRIAL OF SODIUM VALPROATE IN TARDIVE-DYSKINESIA
title A TRIAL OF SODIUM VALPROATE IN TARDIVE-DYSKINESIA
title_full A TRIAL OF SODIUM VALPROATE IN TARDIVE-DYSKINESIA
title_fullStr A TRIAL OF SODIUM VALPROATE IN TARDIVE-DYSKINESIA
title_full_unstemmed A TRIAL OF SODIUM VALPROATE IN TARDIVE-DYSKINESIA
title_short A TRIAL OF SODIUM VALPROATE IN TARDIVE-DYSKINESIA
title_sort trial of sodium valproate in tardive-dyskinesia
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172504/
https://www.ncbi.nlm.nih.gov/pubmed/21927146
work_keys_str_mv AT chaddar atrialofsodiumvalproateintardivedyskinesia
AT kulharap atrialofsodiumvalproateintardivedyskinesia
AT chaddar trialofsodiumvalproateintardivedyskinesia
AT kulharap trialofsodiumvalproateintardivedyskinesia

Ejemplares similares